- Home
- HUN vs IBRX Comparison
HUN vs IBRX Comparison
Compare HUN & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUN
- IBRX
- Stock Information
- Founded
- HUN 1970
- IBRX 2014
- Country
- HUN United States
- IBRX United States
- Employees
- HUN N/A
- IBRX N/A
- Industry
- HUN Major Chemicals
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HUN Industrials
- IBRX Health Care
- Exchange
- HUN Nasdaq
- IBRX Nasdaq
- Market Cap
- HUN 2.9B
- IBRX 2.4B
- IPO Year
- HUN 2005
- IBRX N/A
- Fundamental
- Price
- HUN $15.79
- IBRX $3.01
- Analyst Decision
- HUN Hold
- IBRX Strong Buy
- Analyst Count
- HUN 8
- IBRX 5
- Target Price
- HUN $20.25
- IBRX $11.35
- AVG Volume (30 Days)
- HUN 3.6M
- IBRX 5.6M
- Earning Date
- HUN 05-01-2025
- IBRX 03-03-2025
- Dividend Yield
- HUN 6.32%
- IBRX N/A
- EPS Growth
- HUN N/A
- IBRX N/A
- EPS
- HUN N/A
- IBRX N/A
- Revenue
- HUN $6,036,000,000.00
- IBRX $14,745,000.00
- Revenue This Year
- HUN $5.20
- IBRX $621.53
- Revenue Next Year
- HUN $5.24
- IBRX $163.57
- P/E Ratio
- HUN N/A
- IBRX N/A
- Revenue Growth
- HUN N/A
- IBRX 2270.58
- 52 Week Low
- HUN $15.22
- IBRX $2.28
- 52 Week High
- HUN $26.40
- IBRX $10.53
- Technical
- Relative Strength Index (RSI)
- HUN 37.96
- IBRX 50.60
- Support Level
- HUN $15.79
- IBRX $2.69
- Resistance Level
- HUN $16.76
- IBRX $3.47
- Average True Range (ATR)
- HUN 0.60
- IBRX 0.21
- MACD
- HUN -0.11
- IBRX 0.04
- Stochastic Oscillator
- HUN 21.24
- IBRX 41.77
About HUN Huntsman Corporation
Huntsman Corp is a us-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives most of its revenue from the Polyurethanes segment which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.